Xiidra 50 mg/mL
Lifitegrast · SOLUTION/ DROPS · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
Xiidra is a solution/ drops containing lifitegrast at 50 mg/mL, taken ophthalmic. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- Xiidra
- Generic Name
- Lifitegrast
- NDC Code (Product)
0078-0911- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 50 mg/mL
- Dosage Form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Marketing Status
- Application #
- NDA208073
- Drug Class
- Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]
- Marketing Start
- 07/11/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is Xiidra used for?
Xiidra contains Lifitegrast. It is a solution/ drops taken ophthalmic. Consult your doctor for specific uses.
Is Xiidra a controlled substance?
Xiidra is not classified as a controlled substance by the DEA.
What is the generic name for Xiidra?
The generic name for Xiidra is Lifitegrast. There are 1 other brand versions of Lifitegrast.
What is the NDC code for Xiidra 50 mg/mL?
The NDC (National Drug Code) for Xiidra 50 mg/mL is 0078-0911, listed by Novartis Pharmaceuticals Corporation.